ResMed | RMD - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Ansell USD 1.97B 10.2M 2025-12
Artivion USD 445.58M 4.88M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Cochlear AUD 1.94B 12.2M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
CSL USD 18.66B 2.75B 2025-12
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Fisher Paykel Healthcare NZD 2.12B 129.2M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Haemonetics USD 837.1M 40.78M 2026-06
Idexx Laboratories USD 1.61B 56.47M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
Medtronic USD 48.99B 128M 2025-12
Philips EUR 11.48B 84M 2026-06
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.59B 93.48M 2026-06
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Steris USD 7.21B 23.1M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03